In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FoxHollow Makes First Acquisition, Buys Kerberos

Executive Summary

After much anticipation, atherectomy leader FoxHollow Technologies has finally joined the ranks of the acquirers, buying Kerberos Proximal Solutions, maker of the Rinspiration system, which is a catheter-based system that both rinses and aspirates vessels to remove blood clots and soft emboli. Both companies are currently focusing on treating peripheral vascular disease.

You may also be interested in...

Carotid Stenting: Trials and Tribulations

Today, carotid artery stenting is an accepted less-invasive alternative to surgical endarterectomy for carefully selected patients, particularly those at significant surgical risk, and market projections are very positive. But, the field still has a long way to go before this procedure is considered routine.

In Brief January 2007

A brief summary of recent product developments in the device industry, including updates on Edwards Lifesciences, Cardiophonics, Boston Scientific. Also, short takes on the Pediatric Medical Device Safety and Improvement Act, and Annual Breast Cancer Screening.

Coronis: Creating Virtual Companies

Launched by four veterans of the medical device industry, Coronis Medical hopes to be able to nurture precisely the kind of opportunities that even the most early stage-minded of venture investors can't. Through its relationship with Stellartech, a design and development consulting firm, Coronis will be able to provide a wide array of services for the projects it takes on, creating virtual companies through what is, in effect, a kind of virtual incubator.

Related Content


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts